News tagged ‘BreastCancer’ clear
- A new study suggests that women should be taking the breast cancer drug tamoxifen for twice as long as is now customary. Dr. Eric P. Winer said that even women who completed their five years of tamoxifen months or years ago might consider starting on the drug again. Dr. Judy Garber added that while many women don't feel well while taking hormone therapies like tamoxifen, they consider it their safety net.
Tags: BreastCancer, Hormones, Prevention
- Dr. Harold Burstein said the new data on the extended use of tamoxifen may push more patients to consider longer durations of anti-estrogen therapy, but they will need to be aware of the trade-offs, including mild side-effects and more serious, but rare cancer risks.
Tags: BreastCancer, Hormones, Prevention
- Judy Garber, MD, MPH, discussed the potential clinical implications of the findings from a study from The Cancer Genome Atlas that identified four genetically distinct types of breast cancer.
Tags: BreastCancer, Genomics
- Dr. Javid Moslehi wrote in an editorial that cardiac risk factors should be assessed when a breast cancer patient starts radiation treatment and continued throughout survivorship.
Tags: BreastCancer, Radiation
- Dr. Eric Winer comments on the FDA's recent approval of the breast cancer drug Kadcyla. He says clinical trials show that the drug is both highly effective and has few side effects.
Tags: BreastCancer
- Extending tamoxifen treatment to 10 years significantly improved a women's chances of surviving breast cancer and reduced the risk of the cancer coming back, a new study shows. Dr. Eric Winer said while only about 10 percent of women in the study were premenopausal, the benefits were similar to those for women after menopause, indicating that a new long-term strategy is now an option for them. (Full article requires a subscription)
Tags: BreastCancer, Hormones, Prevention
Showing 11-20 of 34 items